Project Grant K01DK147749
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $819,091 Project Grant on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on glucose patterns and clinical outcomes in the Dallas Heart Study. The research project, which extends through June 30, 2030, applies continuous glucose monitoring (CGM) systems and novel machine...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Utah $161,664 on September 16, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop Diabetes Recommendations Enhanced with AI Models (DREAM). This K01 career development award supports Dr. Polina Kukhareva's research focused on creating predictive artificial intelligence models that leverage large,...
- Federal Grant Award Summary The University of Illinois received a $295,494 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025 through August 31, 2030. This award supports the ACCELERATED-T2D (Accumulation of Elevated Risk Associated with Treatment-Escalation Differences in Patients with Type 2 Diabetes) research initiative,...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $173,232 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 15, 2026, with completion targeted for February 28, 2031. This research initiative investigates renal endothelial cell signaling in sepsis-associated acute kidney injury (SA-AKI) following viral...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $2.38 million Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 7, 2025, through August 31, 2029. This research project investigates the role of histone H3 O-linked β-N-acetylglucosamine (O-GlcNAc) modification in endothelial cells and its...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia a $788,831 Project Grant effective February 1, 2026, through December 31, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds development of a ketone-aware automated insulin delivery (AID) system designed to enable safe use of sodium-glucose cotransporter inhibitors (SGLT-I) in individuals...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a Project Grant totaling $169,927 (award date: April 1, 2026; completion date: March 31, 2031) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds a comparative effectiveness research study evaluating glucose-lowering therapies for people with human immunodeficiency virus (HIV) and type 2...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Colorado-Denver $756,480 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 5, 2025, for a project extending through June 30, 2030. This Project Grant supports research addressing critical evidence gaps in type 2 diabetes management by integrating real-world data from diverse patient populations with data from...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a four-year research initiative (through June 30, 2029) investigating post-transcriptional regulation of hepatokines and systemic metabolism. The research focuses on identifying...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Alabama at Birmingham $152,524.00 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 15, 2026, for a five-year research initiative extending through March 31, 2031. This K01 career development award supports Dr. Seung-Yup "Joshua" Lee in developing an independent research program focused on improving diabetes outcomes through artificial intelligence (AI)-supported interventions targeting high-risk care transitions. The primary deliverable is MedBridge (Medication Bridge at Care Transition), an AI-driven risk stratification tool designed to identify patients with Type 2 Diabetes at elevated risk of adverse outcomes following hospital discharge. The tool integrates medication data (including insulin types and glucagon-like peptide-1 receptor agonists), clinical factors such as glycated hemoglobin levels and comorbidities, and social determinants of health to address medication discrepancies and communication gaps between inpatient and outpatient providers. The award also funds pilot feasibility testing of a tailored intervention delivered by a nurse case manager, with the objective of improving medication management, glycemic control, and reducing diabetes-related emergency department visits and hospitalizations, particularly among socioeconomically disadvantaged populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $152.5k | 5/19/26 |